HK22892A - Ibuprofen sustained release matrix and process - Google Patents

Ibuprofen sustained release matrix and process

Info

Publication number
HK22892A
HK22892A HK228/92A HK22892A HK22892A HK 22892 A HK22892 A HK 22892A HK 228/92 A HK228/92 A HK 228/92A HK 22892 A HK22892 A HK 22892A HK 22892 A HK22892 A HK 22892A
Authority
HK
Hong Kong
Prior art keywords
ibuprofen
sustained release
granulation
release matrix
erosion
Prior art date
Application number
HK228/92A
Other languages
English (en)
Inventor
Galen Wesley Radebaugh
Robert Glinecke
Thomas Nicholas Julian
Original Assignee
Mcneilab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneilab Inc filed Critical Mcneilab Inc
Publication of HK22892A publication Critical patent/HK22892A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK228/92A 1987-04-22 1992-03-26 Ibuprofen sustained release matrix and process HK22892A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/041,164 US4806359A (en) 1987-04-22 1987-04-22 Iburprofen sustained release matrix and process

Publications (1)

Publication Number Publication Date
HK22892A true HK22892A (en) 1992-04-03

Family

ID=21915089

Family Applications (1)

Application Number Title Priority Date Filing Date
HK228/92A HK22892A (en) 1987-04-22 1992-03-26 Ibuprofen sustained release matrix and process

Country Status (21)

Country Link
US (1) US4806359A (fr)
EP (2) EP0290168B1 (fr)
JP (2) JP2519296B2 (fr)
KR (1) KR960007750B1 (fr)
AT (1) ATE86479T1 (fr)
AU (2) AU604110B2 (fr)
CA (1) CA1310272C (fr)
DE (2) DE3865077D1 (fr)
ES (1) ES2039277T3 (fr)
GR (1) GR1000019B (fr)
HK (1) HK22892A (fr)
IE (1) IE62786B1 (fr)
IN (1) IN165929B (fr)
MY (1) MY103076A (fr)
NO (1) NO176203C (fr)
NZ (1) NZ224278A (fr)
PH (1) PH25176A (fr)
PT (1) PT87285B (fr)
SG (1) SG104091G (fr)
WO (1) WO1988008299A1 (fr)
ZA (1) ZA882827B (fr)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5200193A (en) * 1987-04-22 1993-04-06 Mcneilab, Inc. Pharmaceutical sustained release matrix and process
US4999226A (en) * 1988-06-01 1991-03-12 Merrell Dow Pharmaceuticals Inc. Pharmaceutical compositions for piperidinoalkanol-ibuprofen combination
AU4664889A (en) * 1988-11-30 1990-06-26 Schering Corporation Sustained release diltiazem formulation
US5104648A (en) * 1989-02-02 1992-04-14 Mallinckrodt Specialty Chemicals Company High ibuprofen content granulations
US4911921A (en) * 1989-02-02 1990-03-27 Mallinckrodt, Inc. High ibuprofen content granulations
US5085865A (en) * 1989-04-12 1992-02-04 Warner-Lambert Company Sustained release pharmaceutical preparations containing an analgesic and a decongestant
KR920002148A (ko) * 1990-07-03 1992-02-28 안드레아 엘. 콜비 비스테로이드계 소염제에 의해 유발된 위장 증상을 완화시키기 위한 약제 조성물 및 이를 완화시키는 방법
FR2677886B1 (fr) * 1991-06-18 1995-03-31 Adir Comprime matriciel permettant la liberation prolongee d'indapamide apres administration par voie orale.
DE4140185C2 (de) * 1991-12-05 1996-02-01 Alfatec Pharma Gmbh Ein 2-Arylpropionsäurederivat in Nanosolform enthaltendes Arzneimittel und seine Herstellung
DE4140183C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Retardform für ein Flurbiprofen enthaltendes Arzneimittel
DE4140172C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Retardform für ein Ibuprofen enthaltendes Arzneimittel
DE4140184C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Akutform für ein Flurbiprofen enthaltendes Arzneimittel
DE4140179C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Akutform für ein Ibuprofen enthaltendes Arzneimittel
DK138592D0 (da) * 1992-11-17 1992-11-17 Nycomed Dak As Tabletter
US20080075781A1 (en) * 1992-11-25 2008-03-27 Purdue Pharma Lp Controlled release oxycodone compositions
US20070275062A1 (en) * 1993-06-18 2007-11-29 Benjamin Oshlack Controlled release oxycodone compositions
IT1264696B1 (it) * 1993-07-09 1996-10-04 Applied Pharma Res Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata
WO1995035099A1 (fr) * 1994-06-20 1995-12-28 Kv Pharmaceutical Company Schema posologique d'administration de vitamines/substances nutritives
WO1996012476A1 (fr) * 1994-10-20 1996-05-02 Merck & Co., Inc. Formulation pour granulation par voie humide d'un antagoniste du recepteur de la piperazinylcamphorsulfonyl oxytocine
IT1276689B1 (it) * 1995-06-09 1997-11-03 Applied Pharma Res Forma farmaceutica solida ad uso orale
JP3628809B2 (ja) * 1996-06-10 2005-03-16 アルケア株式会社 薬剤徐放性医療用配合物及びその製造方法
US6348216B1 (en) * 1996-06-10 2002-02-19 Knoll Pharmaceutical Company Ibuprofen and narcotic analgesic compositions
US6361794B1 (en) 1996-06-12 2002-03-26 Basf Corporation Method of making ibuprofen and narcotic analgesic composition
US6361796B1 (en) 1996-10-25 2002-03-26 Shire Laboratories, Inc. Soluble form osmotic dose delivery system
AU721653B2 (en) * 1996-10-25 2000-07-13 Supernus Pharmaceuticals, Inc. Soluble form osmotic dose delivery system
EA005291B1 (ru) * 1999-03-31 2004-12-30 Янссен Фармацевтика Н.В. Применение предварительно желатинированного крахмала в композиции с контролируемым высвобождением
CO5200844A1 (es) * 1999-09-17 2002-09-27 Novartis Ag Una combinacion que comprende nateglinida y cuando por menos otro compuesto antidiabetico usada para el tratamiento de desordenes metabolicos, especialmente diabetes, o de una enfermedad o condicion asociada con dibetes
EP1368003A4 (fr) * 2001-02-05 2004-05-12 Scherer Technologies Inc R P Procedes et compositions reduisant le gout de principes actifs
US6602911B2 (en) * 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
WO2003077897A1 (fr) * 2002-03-15 2003-09-25 Cypress Bioscience, Inc. Inhibiteurs de recaptage de 5-ht pour le traitement de syndromes de la douleur viscerale
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20040132826A1 (en) * 2002-10-25 2004-07-08 Collegium Pharmaceutical, Inc. Modified release compositions of milnacipran
CA2513893A1 (fr) * 2003-01-28 2004-08-12 Collegium Pharmaceutical, Inc. Compositions multiparticulaires de milnacipran destinees a etre administrees par voie orale
US8313776B2 (en) 2003-07-21 2012-11-20 Shionogi Inc. Antibiotic product, use and formulation thereof
JP2006528185A (ja) * 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
JP2006528190A (ja) * 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
CA2535398C (fr) * 2003-08-12 2013-11-12 Advancis Pharmaceuticals Corporation Antibiotique, utilisation et formulation associees
AU2004270170B2 (en) * 2003-08-29 2011-01-27 Shionogi, Inc. Antibiotic product, use and formulation thereof
WO2005027877A1 (fr) * 2003-09-15 2005-03-31 Advancis Pharmaceutical Corporation Antibiotique, son utilisation et sa formulation
EP1708684A2 (fr) * 2003-09-26 2006-10-11 Alza Corporation Enrobage de medicaments a charge medicamenteuse elevee et procedes de fabrication
KR20120106757A (ko) * 2003-09-26 2012-09-26 알자 코포레이션 오피오이드 및 비오피오이드 진통제의 제어 방출 제제
NZ586198A (en) * 2003-09-26 2011-12-22 Alza Corp Oros push-stick sustained release dosage forms for controlled delivery of active agents
US20070259033A1 (en) * 2003-09-26 2007-11-08 Evangeline Cruz Controlled release formulations exhibiting an ascending rate of release
JP2008505074A (ja) 2004-06-30 2008-02-21 アルベマール・コーポレーシヨン 高イブプロフェン含有量顆粒並びにそれらの製造および製薬学的薬用量形態中でのそれらの使用
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
US20070077297A1 (en) 2004-09-30 2007-04-05 Scolr Pharma, Inc. Modified release ibuprofen dosage form
US20060099253A1 (en) * 2004-10-20 2006-05-11 Wyeth Antibiotic product formulation
ES2403069T3 (es) * 2005-02-22 2013-05-13 Sun Pharma Advanced Research Company Ltd Composición oral de liberación controlada que contiene levetiracetam
DE102005037630A1 (de) 2005-08-09 2007-02-15 Glatt Gmbh Verfahren zur Herstellung von Teilchen aus pharmazeutischen Substanzen, Teilchen aus pharmazeutischen Substanzen sowie deren Verwendung
US7994220B2 (en) * 2005-09-28 2011-08-09 Cypress Bioscience, Inc. Milnacipran for the long-term treatment of fibromyalgia syndrome
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
GB0525461D0 (en) 2005-12-15 2006-01-25 Archimedes Dev Ltd Pharmaceutical compositions
WO2007069874A1 (fr) * 2005-12-16 2007-06-21 Hanmi Pharm. Co., Ltd. Dispersion solide comprenant un ingredient actif a bas point de fusion et comprime destine a l'administration orale comprenant cette dispersion solide
US7749537B2 (en) 2006-12-04 2010-07-06 Scolr Pharma, Inc. Method of forming a tablet
US8623397B2 (en) 2007-04-13 2014-01-07 The Regents Of The University Of Michigan Delivery device and method for forming the same
US9629806B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
US9629809B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
US8343524B2 (en) * 2008-07-31 2013-01-01 Clarke Mosquito Control Products, Inc. Extended release tablet and method for making and using same
EP2968652B1 (fr) 2013-03-13 2020-07-22 Avery Dennison Corporation Amélioration de propriétés adhésives
CN110037994B (zh) * 2019-05-24 2022-04-12 中国药科大学 一种布洛芬速释缓释双层片及其制备方法
CN114177155B (zh) * 2020-09-08 2023-10-03 越洋医药开发(广州)有限公司 一种布洛芬控释片及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773921A (en) * 1971-11-15 1973-11-20 Hoffmann La Roche Therapeutic compositions
US4264573A (en) * 1979-05-21 1981-04-28 Rowell Laboratories, Inc. Pharmaceutical formulation for slow release via controlled surface erosion
US4308251A (en) * 1980-01-11 1981-12-29 Boots Pharmaceuticals, Inc. Controlled release formulations of orally-active medicaments
US4465660A (en) * 1981-04-01 1984-08-14 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
FR2532177A1 (fr) * 1982-08-30 1984-03-02 Being Well Products Inc Complement nutritionnel a zones de liberation determinees et son procede de fabrication
US4684516A (en) * 1983-08-01 1987-08-04 Alra Laboratories, Inc. Sustained release tablets and method of making same
CA1261260A (fr) * 1984-04-16 1989-09-26 Anil Salpekar Composes de sels de codeine directement compressibles
US4753801A (en) * 1985-10-25 1988-06-28 Eli Lilly And Company Sustained release tablets

Also Published As

Publication number Publication date
KR960007750B1 (ko) 1996-06-12
EP0312581A1 (fr) 1989-04-26
PH25176A (en) 1991-03-27
AU603675B2 (en) 1990-11-22
PT87285B (pt) 1992-08-31
IE881195L (en) 1988-10-22
IN165929B (fr) 1990-02-10
SG104091G (en) 1992-02-14
PT87285A (pt) 1988-05-01
ES2039277T3 (es) 1993-09-16
KR880012213A (ko) 1988-11-26
EP0290168A1 (fr) 1988-11-09
NO176203C (no) 1995-02-22
JP2519296B2 (ja) 1996-07-31
CA1310272C (fr) 1992-11-17
AU604110B2 (en) 1990-12-06
JPS63280021A (ja) 1988-11-17
US4806359A (en) 1989-02-21
ATE86479T1 (de) 1993-03-15
DE3879080T2 (de) 1993-07-15
JP2776856B2 (ja) 1998-07-16
NO881732L (no) 1988-10-24
JPH01503070A (ja) 1989-10-19
MY103076A (en) 1993-04-30
GR1000019B (el) 1990-01-31
DE3865077D1 (de) 1991-10-31
EP0290168B1 (fr) 1991-09-25
AU1477488A (en) 1988-10-27
EP0312581B1 (fr) 1993-03-10
NZ224278A (en) 1990-09-26
NO881732D0 (no) 1988-04-21
WO1988008299A1 (fr) 1988-11-03
DE3879080D1 (de) 1993-04-15
IE62786B1 (en) 1995-02-22
ZA882827B (en) 1989-12-27
GR880100258A (en) 1989-01-31
NO176203B (no) 1994-11-14
AU1719788A (en) 1988-12-02

Similar Documents

Publication Publication Date Title
HK22892A (en) Ibuprofen sustained release matrix and process
GR1000254B (el) Μεθοδος παρασκευης διαμορφωσεως ακεταμινοφαινης βραδειας απελευθερωσεως απο το στομα.
KR880010757A (ko) 제약정제, 제약과립 및 그의 제조방법
ES2055177T3 (es) Composicion de gemfibrozil con liberacion modificada.
TR200200688T2 (tr) Doğrudan tablet şeklinde preslenebilen ultra ince asetaminofen terkipleri ve bu terkiplerin üretim prosesi
AU2793989A (en) Method for preparing a solid sustained release form of a functionally active composition and the dosage form so obtained
GB1296505A (fr)
FI864207A (fi) Kontrollerad frigivning av kaliumklorid.
ATE124257T1 (de) Granulate mit hohem ibuprofengehalt.
EP0070178A3 (fr) Nouvelles formulations du bendrofluméthiazide
DE3883098D1 (de) Spruehgetrocknete ibuprofen-zusammensetzungen.
FR2106566A1 (en) Tabletting active materials - by compressing encapsulated particles
JPS54126722A (en) Slow release antibiotic tablet
KR970000894B1 (ko) 정제형(tablet)산소발생제
HU904109D0 (en) Process for the production of solid medical preparations
TH6682EX (th) สูตรผสมแอเซทามิโนเฟนชนิดปลดปล่อยเป็นเวลานานสำหรับใช้ทางปากและกรรมวิธีในการผลิต
TH6682A (th) สูตรผสมแอเซทามิโนเฟนชนิดปลดปล่อยเป็นเวลานานสำหรับใช้ทางปากและกรรมวิธีในการผลิต
KR840001829A (ko) 새로운 이펜프로딜을 함유하는 정제의 제조방법
KR950031064A (ko) 젬피브로질 함유 약제학적 조성물

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)